Skip to search formSkip to main contentSkip to account menu

afamelanotide

Known as: N-Acetyl-L-serinyl-L-tyrosyl-L-seryl-(2S)-2-aminohexanoyl-L-glutamyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophanylglycyl-L-lysyl-L-prolyl-L-valinamide 
A synthetic peptide analogue of the naturally occurring alpha-melanocyte stimulating hormone (a-MSH) with potential photoprotective activity… 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (3)

CUV1647Melanotan IScenesse

Broader (1)

alpha-Melanocyte stimulating hormone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Porphyrien – was ist gesichert?
ZusammenfassungKlinisch und ätiologisch werden Störungen der Hämbiosynthese in akute bzw. nichtakute und erythropoetische bzw… 
2018
2018
Schwerpunkt : Was ist gesichert in der Therapie ?
Porphyrias are caused by enzyme defects of heme biosynthesis. According to their clinical presentation and to each affected… 
Review
2017
Review
2017
Congenital erythropoietic porphyria (Gunther disease) - long-term follow up of a case and review.
Patients with the rare genodermatosis congenitalerythropoietic porphyria (CEP, Gunther disease)develop erosions and scarring on… 
2016
2016
Existing therapies and therapeutic targets for erythropoietic protoporphyria
ABSTRACT Introduction: Erythropoietic protoporphyria (EPP) is a metabolic disorder of heme-biosynthesis that is caused by an… 
2013
2013
Afamelanotide for the treatment of erythropoietic protoporphyria
Introduction: Erythropoietic protoporphyria (EPP) is characterized by incapacitating pain in the sunlight-exposed skin areas due… 
2013
2013
A bioassay for the detection of neutralizing antibodies against the α-melanocyte stimulating hormone analog afamelanotide in patients with erythropoietic protoporphyria.
2013
2013
Dermatology in the artwork of Leonardo da Vinci.
regulator of human cutaneous pigmentation. Pigment Cell Res. 2000;13(suppl 8):156-162. 14. Luger TA, Scholzen TE, Brzoska T, Böhm… 
2011
2011
Pseudoleucoderma after injections of afamelanotide in a patient with atopic dermatitis.
© 2011 The Authors. doi: 10.2340/00015555-1062 Journal Compilation © 2011 Acta Dermato-Venereologica. ISSN 0001-5555 Alpha… 
2011
2011
A randomized phase III trial of afamelanotide (Scenesse®), an agonistic alpha-melanocyte-stimulating hormone (MSH) analogue in the treatment of protoporphyria-induced phototoxicity.
2004
2004
Forum
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)